# Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo

> **NCT01734824** · PHASE4 · SUSPENDED · sponsor: **Medical University of Vienna** · enrollment: 90 (estimated)

## Conditions studied

- Bone Marrow Oedema Syndrome
- High Turnover Bone Disease
- Quality of Life

## Interventions

- **DRUG:** Denosumab
- **DRUG:** Teriparatide
- **DRUG:** Placebo Denosumab
- **DRUG:** Placebo Teriparatide

## Key facts

- **NCT ID:** NCT01734824
- **Lead sponsor:** Medical University of Vienna
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2012-05
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 90 (ESTIMATED)
- **Why stopped:** no patients randomized
- **Last updated:** 2015-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01734824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01734824, "Treatment of Atraumatic Bone Marrow Edema With Denosumab and Teriparatide vs Placebo". Retrieved via AI Analytics 2026-06-07 from https://api.ai-analytics.org/clinical/NCT01734824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*